Analyst All-Stars
Take advantage of Wall Street's collective wisdom with this portfolio of top-rated stocks. These companies have earned strong 'Buy' ratings from respected financial analysts because of their solid fundamentals and potential for market outperformance.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Broadcom Inc.
AVGO
Current price
$294.91
A semiconductor and software giant, it is consistently rated 'Buy' by analysts due to its market leadership and integral role in global technology inf...
A semiconductor and software giant, it is consistently rated 'Buy' by analysts due to its market leadership and integral role in global technology infrastructure.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
This collection harnesses the collective intelligence of Wall Street's most trusted analysts. By focusing on companies with strong consensus 'Buy' ratings, we're leveraging deep institutional research to identify businesses with robust fundamentals and clear paths to growth.
What You Need to Know
These stocks span diverse industries from technology to finance, offering built-in diversification. Each company has passed rigorous professional scrutiny of its financial health, competitive position, and management quality, creating a growth-oriented portfolio backed by expert validation.
Why These Stocks
Each company was selected because it earned a 'Strong Buy' or 'Buy' rating from a significant majority of analysts covering it. In a market overwhelmed with information, this expert consensus acts as a critical filter for identifying quality stocks with higher probability of outperformance.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+172.76%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 172.76% over the next year.
Stocks Rated Buy by Analysts
15 of 15 assets in this group are rated Buy by professional analysts.
Group Growth vs Bank interest
This group averaged a 4.5% return last month, beating the typical 4% bank rate.
Why You'll Want to Watch These Stocks
Wall Street's Best Thinking
These stocks represent the distilled wisdom of countless hours of professional research. When top analysts agree on a company's potential, it's worth paying attention.
Professionally Vetted Winners
Feel more confident knowing these companies have passed through rigorous scrutiny. Every stock has been thoroughly analyzed for financial health, competitive positioning, and growth potential.
Hidden Gems Across Industries
Discover opportunities you might have missed. This diverse collection spans tech innovators, healthcare pioneers, and financial leaders - all backed by professional conviction.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Orphan Drug Moats: Leaders In Rare Disease
The FDA's rejection of PTC Therapeutics' drug for a rare genetic disorder has delayed a new treatment option and created a significant setback for the company. This regulatory decision strengthens the competitive position of companies with already-approved therapies for rare diseases, highlighting the value of a proven drug portfolio.
Nvidia's China Chip Pivot
Nvidia is developing a new, compliant AI chip for China, aiming to recapture market share lost to U.S. export controls. This strategic pivot creates a ripple effect, potentially benefiting the entire semiconductor supply chain that supports the production and deployment of this advanced hardware.
Navigating The Autonomous Driving Shakeout
A class-action lawsuit against Tesla regarding its Full Self-Driving claims puts the company's marketing and technology under intense scrutiny. This legal challenge could boost demand for competing autonomous driving technologies, creating opportunities for companies that supply advanced sensors and software.
Frequently Asked Questions
Everything you need to know about the product and billing.